To create a statistical tool for the estimation of extracapsular extension (ECE) level of prostate cancer and determine the nerve-sparing (NS) approach that can be safely performed during radical prostatectomy (RP).
Introduction
The introduction of nerve-sparing (NS) radical prostatectomy (RP) in 1983 improved the potency and continence outcomes in the treatment of clinically localised prostate cancer [1, 2] . Whilst preservation of the neurovascular bundle (NVB) improves the chance of recovering erectile function, it may lead to an increased incidence of positive surgical margins (PSM) [3] . To maximise the functional outcome whilst maintaining quality of cancer care, the NS approach has changed from an absolute ('all-or-none') approach to a graded approach.
According to our prior publication, we proposed that NS can be graded into five levels, depending on the amount of tissue the surgeon decides to leave on each side [4, 5] . Various papers have shown that NS classification according to the surgeon's intraoperative perception correlates with the residual nerve tissue found on specimens [6] [7] [8] [9] .
Knowledge of the presence and extent of extracapsular extension (ECE) before surgery would help surgeons tailor the amount of NS. Several tools can predict the presence of ECE or other outcomes and most of them are based on routinely available variables [10] [11] [12] [13] . However, to our knowledge, there are no algorithms supporting preoperative planning with quantification not only of the presence of ECE but of the amount of ECE, this information is crucial in order to make an appropriate, standardised decision between a full NS, a partial NS, or a wide excision.
The aims of the present study were three-fold: to describe the amount of ECE, to develop a predictive model of the presence and amount of ECE, and to develop a decision rule to assist the surgeon in the trade-off between NVB preservation and absence of PSM.
Patients and Methods
A total of 11 794 prostatic lobes, from a cohort of 6 360 patients who underwent robot-assisted laparoscopic prostatectomy (RALP) between January 2008 and January 2016 by a single surgeon were evaluated.
No centralised revision of the core biopsies was done; only those patients with <5% of disease and one positive core were reviewed by a single expert pathologist (D.K.) (2.8%). As far as the final prostate specimen was concerned, after a proper processing, the slides were examined for the presence of ECE. ECE was defined as the presence of tumour beyond the confines of the prostate [14] , independently from seminal vesicle involvement, which was not the focus of our investigation. The maximum continuous length of ECE was recorded, along with its 'width' (perpendicular dimension from the capsule to the furthest extent of the ECE). At other locations, where the prostatic capsule was not evident, a best estimation was made for the distance of invasion into periprostatic soft tissue. Patients with <3 cores/lobe (3.3%) or on preoperative medical therapies, such as hormone (2.2%) or 5a-reductase inhibitors (0.6%), were excluded; overall, 408 patients were excluded (6%).
The Predictive Algorithm
The building blocks of the proposed prediction algorithm are shown in Fig. 1 . The algorithm was built with the aim of predicting different degrees of extracapsularity for each lobe. Five binary outcomes were considered: the presence of ECE and ECE width of >1, >2, >3, and >4 mm. We decided to focus our prediction in the range from 0 to 4 mm because in our cohort >95% of pT3 disease had ECE within 5 mm.
Variable Selection
The list of preoperative characteristics considered as potential predictors of ECE and used in the variable selection are recorded in Table S1 .
The selection of the predictive covariates was performed using the area under the receiver operating characteristic curve (AUC) of the random forest algorithm [15] , which maximises the AUC of random forests [16] . Its advantage is the ability to evaluate the predictive power of each covariate individually, as well as in multivariate interactions with other predictors [17] .
Model Estimation
The covariates selected as predictors were used as explanatory variables in the estimation of the multivariable logistic regression models for the five ECE outcomes. The goodnessof-fit of these models was investigated using calibration curves, which evaluate the agreement between observed and predicted probabilities. The predictive power of the models was evaluated estimating sensitivity and specificity for different thresholds on the predicted probabilities, plotting the receiver operating characteristic (ROC) curve and calculating the AUC. The AUC was also estimated using repeated k-fold cross-validation.
Personal Profile Plot
The predictions yielded by the five regression models were used to draw for each patient and each lobe a personal profile plot, which shows the predicted probabilities for different ECE widths.
Decision Rule
For each amount of ECE, a five-zone decision rule was developed (the multi limen rule, henceforth) (Fig. S1 ) [18] . Four thresholds were estimated for each model: an upper and an upper-middle threshold corresponding to a maximum rate of false positives (FP) of 10% and 20%, respectively, a lower and a lower-middle threshold corresponding to a maximum rate of false negatives (FN) of 10% and 20%, respectively (threshold calculation in the multi limen decision rule provided in Appendix S1). Overall, the decision rule works using a set of 20 thresholds. The aim of these thresholds is to classify each estimated probability of ECE width into five areas: a green and a light green zone characterised respectively by low and medium rates of FN, a light red and a red zone characterised by medium and low rates of FP, and 374 © 2017 The Authors BJU International © 2017 BJU International a yellow intermediate zone with higher rates of decision errors. In the green and red zones, the decision rule provides suggestions to the surgeon regarding the boundaries of the resection. In the yellow zone additional diagnostic tools, e.g., multiparametric MRI (mpMRI), might be advisable and the surgical strategy should be evaluated more carefully.
Graphical Interface
To make this tool easily accessible, a user-friendly graphical interface was developed. Using this tool the surgeon can view all of the patient's main pre-treatment information, together with the plot of estimated probabilities for different amounts of ECE and the multi limen decision rule.
Results
Clinical and pathological characteristics of the study population are summarised in Figure 1 Building blocks of the proposed prediction algorithm.
risk of ECE was virtually absent beyond 10 mm outside of the prostate, the spatial distribution of ECE is represented in Fig. S2 . The median (IQR; range) ECE length was 3.0 (1.0-7.0; 0.1-40.0) mm. In 1 876 lobes (15.9%) the number of core samples was between three and five, in 9 106 lobes (77.2%) it was six cores, and in 812 lobes (6.9%) there were more than six cores. Table S2 shows the univariate analysis of the association between clinicopathological characteristics and the frequency of lobes with ECE and with ECE width of >1, >2, >3, and >4 mm. The data reported showed increasing values of ECE widths for increasing age, levels of PSA, clinical stage, percentage of positive cores, maximum percentage of positive core, and Gleason score. All these associations were statistically significant (P < 0.001).
Variable Selection
Variable selection identified seven predictors of ECE: age, total PSA (logarithm), clinical stage, average percentage of cancer, ratio of number of cores with percentage of cancer >60% and number of positive cores, ratio of the number of cores with Gleason score >6 and number of positive cores, and rate of positive cores. The last two variables did not enter the models for ECE widths of >2, >3 and >4 mm. Table 2 records the multivariable odds ratios of the seven selected variables for each logistic model; positive and statistically significant associations between outcomes and predictors were found (P ranging from <0.001 to 0.029). The coefficients of the logistic models are reported in Table S3 .
Model Estimation
The calibration curve of the regression model used to predict the presence of ECE is shown in Fig. 2 . The bias-corrected curve, close to the straight line of the ideal predictor, showed that the probabilities calculated with this model accurately reproduce the actual outcomes. Figure S3 shows the calibration curves of the remaining models.
ROC curves of the regression model and their AUCs are listed in Fig. 3 . All the models showed good predictive performances with AUCs ranging from 0.81 to 0.90 (P < 0.001). These results were confirmed by repeated (100 replications) 10-fold cross-validation (Table S4) .
Personal Profile Plot
Probabilities of ECE widths were calculated for each patient. An example is presented in Fig. S4 .
Decision Rule
At each step of the decision process the thresholds characterised by maximum FN and FP decision errors of 10% and 20% were calculated. The set of 20 thresholds are recorded in Table S5 . Application of the decision rule to the predicted probabilities leads to the classification of each ECE probability into one of the five zones characterised by different levels of decision errors. An example is depicted in Fig. S5 . Risk comparisons between the five zones identified by the decision rule are shown in Figs S6 and S7.
Graphical Interface
All the relevant information regarding a patient, the profile plots for the two lobes, and the areas defined by the multi limen decision rule were summarised by a graphical interface (Fig. 4) . The output includes four panels. The top left panel is subdivided into 12 coloured boxes; every box represents a biopsy core in its location (e.g. top left, first row: LLA, left lateral apex) and reports the number, percentage, and For the left lobe, the probability of ECE was 4.7% and was located inside the light green area; the probabilities of ECE width of >1, >2, >3 and >4 mm were 2.1%, 1.0%, 0.4% and 0.3%, respectively, all inside the green area. Hence, the multi limen rule gave an indication for a full NS. For the right lobe, the five ECE probabilities were 46.7% (red), 20.5% (light red), 7.9% (yellow), 3.6% and 3.2% (light green), respectively. The decision rule suggested avoiding a full NS, evidenced a consistent risk of ECE width of >1 mm, and a moderated risk of ECE width of >3 mm. The final pathology revealed intracapsular disease on the left side and 2 mm of ECE on the right.
Other examples are shown in Figs S8 and S9. 
Web-Based Accessibility
To facilitate the use of the proposed prediction method, we set up an easy-to-use web-based interface, freely available at the link: www.prece.it. On this website, the user can input the data of his/her patient and get the prediction of amount and side of ECE.
Discussion
ECE is found on pathological analysis of prostate cancer specimens in a significant number of patients with preoperatively clinically localised prostate cancer who undergo RALP [19, 20] . Maubon et al. [21] reported that not only the presence, but even the amount of ECE is an independent predictive factor of biochemical recurrence (BCR). Wheeler et al. [22] reported a 5-year BCR rate of 13% in patients with organ-confined prostate cancer, whereas in patients with local ECE the rate was as high as 27%. In the same study, ECE was reported as an independent predictor for BCR.
Based on this background, it would be valuable to assess the risk of ECE before surgery to make decisions regarding the balance between cancer control and functional recovery. Furthermore, the introduction of robotic surgery has led to new ideas in terms of NS: from an 'all-or-none' to a more graded approach. In 2012, we reported a subjective graded approach to NS divided into five different levels [5] . This graded concept was contrary to an all-or-nothing approach, the challenge was to estimate the level of ECE and spare the amount of the NVB appropriate enough to excise the cancer but maximally preserve functional neurovascular tissue. However, to date, it has not been possible to standardise the decision-making process on when to take a more or less conservative approach.
Predictive tools available to date and new imaging techniques only partially support the process. Particularly, nomograms based on clinicopathological features usually perform better than any individual predictive factor, informed clinical judgment, or easy-to-remember tools such as risk groups [22, 23, 24] . Preoperative factors are used in several nomograms as reliable predictors of ECE; Ohori et al. [25] and Steuber et al. [26] , amongst others, developed algorithms predicting the presence and side of ECE, the former based on 763 patients, with an AUC ranging from 0.78 to 0.80, the latter on 1 118 patients and a C-index of 84%. These nomograms should support the surgeon in performing a wider excision. However, they calculate a probability of ECE, but neither a decision rule nor a prediction of the amount of ECE is provided. In other words, it is hard to decide when and how wide to perform a dissection in the peri-prostatic tissue based on a generic percentage of risk of ECE.
On the other hand, mpMRI is increasingly used for prostate cancer imaging, as a support for target biopsies and to determine the extension of the prostate cancer. Furthermore, mpMRI has been investigated for its possible role in local staging. However, according to a recent meta-analysis published on a total of 75 studies (9 796 patients), the overall sensitivity and specificity for the detection of ECE were only 0.57 (95% CI 0.49-0.65) and 0.91 (95% CI 0.88-0.93), respectively [27] (even though, MRI and clinical-based and (E) ROC curve of the models predicting an ECE width greater than 1, 2, 3, 4 mm, respectively.
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© 2017 The Authors BJU International © 2017 BJU International models combined may improve prediction of non-organconfined disease, particularly for ECE and seminal vesicle involvement) [28] [29] [30] . Consequently, surgeons usually base their decision on preoperative variables and intraoperative visual clues [31] ; however, this is far from being a safe, standardised and reproducible approach.
To address these issues, we evaluated the concept of the amount of ECE and developed a model capable of predicting with a good accuracy not only the presence but even the extent of ECE in patients undergoing RALP. In addition, we developed a decision rule to assist surgeons in their decisionmaking process. The graphical tool and the multi limen rule provide a simple visual clue of the predicted ECE, with a clear indication of the error level associated to the prediction.
We have previously described that the 'landmark artery', a branch of the pudendal artery, can be used anatomically to grade the amount of NS [4] . However, notwithstanding the accurate description of the anatomical landmark considered in the differentiation of the type of NS [5], it might not be easy, particularly for less experienced surgeons, to identify such specific landmarks. Therefore, the prediction in terms of millimetres of ECE might be of help to plan the width of dissection, even without identifying specific anatomical landmarks of the NS.
The decision to define prediction between 0 and >4 mm out of the prostatic capsule is related to the fact that in the present cohort, 97.6% of the patients had disease within 5 mm.
It is worth pointing out that the proposed prediction system is not intended to replace individualised clinician-patient decision-making, but rather to provide a straightforward instrument to facilitate ECE probability assessment.
Our present study has several noteworthy strengths.
• The large sample size.
• The adoption of an approach that goes beyond the prediction of the presence of ECE; focusing on the estimation of probabilities of ECE width of >1, >2, >3, and >4 mm, the proposed predictive algorithm yields for each • Unlike previous studies, our present tool provides a decision rule integrated in an interface to make interpretation of outcomes easy for surgeons.
• The availability of an easy-to-use, free, web-based interface.
• The diffusion of this tool might improve standardisation and comparability of future studies in terms of PSM.
• The tool highlights the importance of millimetre-level ECE measurement. Although the prognostic role of accurate ECE measurement is unclear [21] , it might be useful in order to appropriately compare different series (e.g., the PSM percentage in a series with 1 mm median ECE, might be lower compared to a series with 3 mm median ECE, and this should be related to intrinsic patient characteristics rather than surgical issues).
The present study has some limitations.
• The models have been developed and calibration has been performed; nevertheless, an external validation is needed to confirm the quality of the predictions and the reproducibility of the tool.
• The five models showed predictive performances that ranged from good to excellent according to the AUC. Nevertheless, the proposed predictive tool is based only on clinicopathological factors and this could limit the accuracy of the models. Several recent studies have assessed the value of preoperative MRI in patients for evaluation of ECE [31] [32] [33] [34] [35] , suggesting that prediction accuracy may be increased by integrating radiological information into predictive models; further prospective studies are needed to integrate our model with imaging tools.
• In addition, the study is based on a North American cohort from a single institution, with a limited number of Afro-American patients and several Caucasians; a geographic bias may affect the generalisability of our present findings. Even though Steuber et al. [26] showed that multivariate nomograms on side-specific ECE and their predictions are relatively unaffected by population differences, an external validation with different racial/ ethnic groups is advisable in the future.
• Moreover, the population of the study is mostly low-risk tumours (43%) with a relatively limited number of highrisk patients.
To our knowledge, the present study is the first to propose an evidence-based statistical tool that can be used to predict, not only the presence, but even the amount of ECE in prostate cancer specimens. This tool demonstrated good accuracy and, thanks to its user-friendly decision rule, can provide valuable assistance to surgeons in their preoperative planning.
In our present algorithm, the added predictive value of imaging tools needs to be carefully evaluated in future research, taking into account the additional healthcare costs involved.
Supporting Information
Additional Supporting Information may be found in the online version of this article: Figure S1 . Block diagram of the five-stage multi limen decision rule. At the first stage, the rule gives support for deciding between absence or presence of ECE; the probability estimated by the first logistic model falls in one of the five zones, one green and one light green zone (characterised by 10% and 20% maximum percentage of false negative, respectively), one intermediate yellow zone, one light red and one red zone (characterised by 20% and 10% maximum percentage of false positive, respectively). If the second stage is reached, the decision rule gives support for deciding between ECE inside the interval (0,1) and ECE >1 using the probability estimated by the second logistic model and the five zones (characterised by different levels of the maximum false negative or false positive errors and calculated under the condition of being ECE positive).
Step after step, the rule enables the surgeon to decide the amount of ECE that could be reasonably associated to the lobe, keeping error rates under control. Figure S2 . Spatial distribution of ECE. Figure S3 . Analysis of the goodness-of-fit of the logistic model used to predict the presence of ECE with a width of >1, >2, >3, and >4 mm: calibration curves. Figure S4 . Example of personal profile plot for a patient; predicted probabilities for the presence of ECE (>0) and for ECE width of >1, >2, >3, and >4 mm are plotted for each prostate lobe. Figure S5 . Example of personal profile plot with five-coloured zones characterised by different levels of decision errors: green = zone characterized by a maximum rate of false negatives of 10%, light green = zone with a maximum rate of false negatives of 20%, yellow = intermediate zone, light red = zone with a maximum rate of false positive of 20%, red = zone with a maximum rate of false positive of 10%. Figure S6 . Risk comparison of the presence of ECE between the five zones identified by the multi limen decision rule: estimated odds ratios with 95% CIs (the reference class is the green zone). Figure S7 . Risk comparison of ECE width of >1 mm (a), >2 mm (b), >3 mm (c), and >4 mm (d) between the five zones identified by the multi limen decision rule: estimated odds ratios (the reference class is the green zone). Figure S8 . In the case of patient 6 134 there are four positive cores in the left lobe: left lateral base (20% of the core, Gleason score 7), left base (15% of the core, Gleason score 7), left lateral median (89% of the core, Gleason score 8), left median (60% of the core, Gleason score 7); the total PSA level is 7.4 ng/mL and the clinical stage is T1c. In this lobe the estimated probability of tumour presence (first dot) at the level of the prostatic capsule is 45%. This value is positioned in the red zone and, according to the decision rule, it is highly unsafe to perform a nerve-sparing excision along the prostatic capsule. The risk of ECE >1 mm is 15% (light red zone), of ECE >2 mm is 5% (yellow zone) and of ECE width of >3 mm is 3% (light green area), indicating with a reasonable degree of confidence that the excision of periprostatic tissue should be planned above 1 mm and not beyond 3 mm. The final observed ECE width for this lobe is 3 mm. On the other lobe, there is only one positive core (right lateral median, 10% tumour positive, Gleason score 6). As expected, the estimated probability of ECE is small (5%, light green zone) and the decision rule suggests a full nerve sparing can be carried out with only a 3% of risk and the prediction of a complete safe dissection. Figure S9 . In the example of patient 4 755, there are 4/6 cores with various levels of involvement and Gleason score up to 9 in the left lobe, whereas only one positive core with Gleason score of 9 in the right lobe. Clinical stage is T1c and PSA level is 6 ng/mL. According to the prediction and the decision rule, on the left side there is a reasonable safety at no <2 mm from the prostatic capsule, whereas on the right side, the light green area is at 1 mm outside of the prostate. The pathology report recorded a bilateral ECE of 1 mm. The prediction of the left side was moderately more conservative than the real outcome. Table S1 . List of preoperative characteristics considered as potential predictors of ECE and used in variable selection; if there was no cancer on one side, ipsilateral Gleason score, maximum percentage of cancer and percentage of positive cores were counted as zero. Table S2 . Frequency of ECE in prostate lobes according to clinical and biopsy features. Table S3 . Estimated coefficients of the five logistic models that can be used to calculate the predicted probabilities for a prostate lobe given the values of the predictors. Table S4 . Area under the curves (AUC) estimated using repeated 10-fold cross-validation (100 replications): median value and percentile interval (2.5-97.5%). Table S5 . Estimated values of the 20 thresholds in the multi limen decision rule. Appendix S1. Supplementary material.
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